Join us for a poster highlight of the top abstracts from the MASLD SIG. 
 

Presenters in this symposium focus on the varied functions of liver endothelial cells (ECs). ECs are specialized cells increasingly recognized for their heterogeneity and their key role in liver diseases and carcinogenesis. Recent advances in the understanding of EC function were made possible with refined isolation techniques coupled with multiomics studies. Speakers review emerging literature that defines liver ECs beyond their role as vascular barriers to critical mediators in various biological processes under physiologic and pathologic conditions. 

This session will explore the clinical significance of comprehensive biomarker testing in chronic hepatitis B (CHB), focusing on how quantitative and qualitative HBsAg, HBeAg, and HBV DNA testing can help offer more personalized care to CHB patients by characterizing disease phases, supporting better-informed treatment decisions, and improving monitoring strategies.

Industry Supporter: GSK

This engaging, interactive session kicks off with an advocate leader hosting "Excuses Bingo," challenging participants to recognize and move past the barriers that hold us back. From there, we hear from a passionate leader in advocacy who shares a message of hope and empowerment. Leading medical experts then offer insights on hope through science, discussing breakthroughs across a spectrum of liver diseases. Finally, a diverse panel explores the shared struggles and victories across liver diseases, emphasizing impact, progress, and the unifying hope that connects us all. No matter the diagnosis, we move forward together—passing the baton toward a healthier future.

Join us for a poster highlight of the top abstracts from the Alcohol-associated Liver Disease (ALD) SIG. 

The following poster categories will be in the Poster Hall:

• Hepatobiliary Neoplasia
• Health Services and Public Health Research
• Liver Transplantation and Liver Surgery
• Liver Fibrogenesis and Non-Parenchymal Cell Biology
• Metabolic and Genetic Disease

The following poster categories will be in the Poster Hall:

• Diagnostics and Biomarkers - MASLD and MASH
• Health Disparities/Health Equity Research
• MASLD/MASH -Epidemiology and Natural History, Prevention and Outcomes
• Hepatitis - Other Infections
• Advanced Practice Providers (NP, PA, RN, PharmD, etc.)
• Portal Hypertension and Other Complications of Cirrhosis
• MASLD/MASH -Treatment: Non-pharmacologic

This interactive symposium will feature expert perspectives on advancing the standard of care for individuals living with PBC. Discussion will focus on strategies aimed at achieving normalization of biochemical markers, alleviating symptom burden, and exploring the potential role of new and emerging therapies in improving patient outcomes.

Supported by: Gilead Sciences, Inc.
Organized by: Clinical Care Options, LLC

For more information and to register, visit: https://clinicaloptions.com/events/pbc-care-innovations/pbc-care-innovations/21863-36103

Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.

Invitation only!

Join us for a poster highlight of the top abstracts from the Hepatitis C SIG.